Reactive oxygen species and angiotensin II signaling in vascular cells - Implications in cardiovascular disease

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 8, 2004, Pages 1263-1273

  Touyz, R M ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Inflammation; Reactive oxygen species; Remodeling; Signal transduction; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CALCIUM ION; ION CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSCRIPTION FACTOR;

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL GROWTH; CELL MIGRATION; DOWNSTREAM PROCESSING; EXTRACELLULAR MATRIX; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; MODULATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN MODIFICATION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 4444333896     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000800018     Document Type: Review

References (60)

1. Wolf G & Wenzel UO (2004). Angiotensin II and cell cycle regulation. Hypertension, 43: 693-698.
2. Touyz RM & Schiffrin EL (2000). Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacological Reviews, 52: 639-672.
3. Touyz RM (2000). Oxidative stress and vascular damage in hypertension. Current Hypertension Reports, 2: 98-105.
4. Wilcox CS (2002), Reactive oxygen species: roles in blood pressure and kidney function. Current Hypertension Reports, 4: 160-166.
5. Griendling KK, Sorescu D & Ushio-Fukai M (2000). NADPH oxidase. Role in cardiovascular biology and disease. Circulation Research, 86: 494-501.
6. Touyz RM, Chen X, He G, Quinn MT & Schiffrin EL (2002). Expression of a gp91phox-containing leukocyte-type NADPH oxidase in human vascular smooth muscle cells - modulation by Ang II. Circulation Research, 90: 1205-1213.
7. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C & Alexander RW (2002). Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circulation Research, 91: 1160-1167.
8. Rey FE & Pagano PJ (2002). The reactive adventitia: fibroblast oxidase in vascular function. Arteriosclerosis, Thrombosis, and Vascular Biology, 22: 1962-1971.
9. Babior BM, Lambeth JD & Nauseef W (2002). The neutrophil NADPH oxidase. Archives of Biochemistry and Biophysics, 397: 342-344.
10. Lassegue B & Clempus RE (2003). Vascular NAD(P)H oxidases: specific features, expression and regulation. American Journal of Physiology, 285: R277-R297.
11. Fridovich I (1997). Superoxide anion radical, superoxide dismutases, and related matters. Journal of Biological Chemistry, 272: 18515-18517.
12. Han D, Antunes F, Canali R, Rettori D & Cadenas E (2003). Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. Journal of Biological Chemistry, 278: 5557-5563.
13. Schafer FQ & Buettner GR (2001). Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biology and Medicine, 30: 1191-1212.
14. Darley-Usmar V, Wiseman H & Halliwell B (1995). Nitric oxide and oxygen radicals, a question of balance. FEBS Letters, 369: 13-15.
15. Channon KM & Guzik TJ (2002). Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. Journal of Physiology and Pharmacology, 53: 515-524.
16. Halliwell B (1999). Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radical Research, 31: 261-272.
17. Forman HJ, Torres M & Fukuto J (2002). Redox signaling. Molecular and Cellular Biochemistry, 234-235: 49-62.
18. Forman HJ & Torres M (2002). Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. American Journal of Respiratory and Critical Care Medicine, 166 (Part 2): S4-S8.
19. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ & Diez J (2001). Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension, 38: 1395-1399.
20. Landmesser U & Harrison DG (2001). Oxidative stress and vascular damage in hypertension. Coronary Artery Disease, 12: 455-461.
21. Saito Y & Berk BC (2001). Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. Journal of Molecular and Cellular Cardiology, 33: 3-7.
22. Suh Y, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK & Lambeth JD (1999). Cell transformation by the superoxide-generating oxidase mox 1. Nature, 401: 79-82.
23. Cheng G, Cao Z, Xu X, van Meir EG & Lambeth JD (2001). Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene, 269: 131-140.
24. Sorescu D, Weiss D, Lassegue B et al. (2002). Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation, 105: 1429-1435.
25. Bengtsson SH, Gulluyan LM, Dusting GJ & Drummond GR (2003). Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clinical and Experimental Pharmacology and Physiology, 30: 849-854.
26. Banfi B, Clark RA, Steger K & Krause K-H (2003). Two novel proteins activate superoxide generation by the NADPH oxidase Nox1. Journal of Biological Chemistry, 278: 3510-3513.
27. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H & Iida M (2004). Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation, 109: 227-233.
28. Wingler K, Wunsch S, Kreutz R, Rothermund L, Paul M & Schmidt HH (2001). Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radical Biology and Medicine, 31: 1456-1464.
29. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg G, McMurray JJV & Dominiczak AF (2000). An investigation into the sources of superoxide production in human blood vessels: Ang II increases superoxide production in human internal mammary arteries. Circulation, 101: 2206-2212.
30. Touyz RM & Schiffrin EL (2001). Increased generation of superoxide by angiotensin II is mediated via PLD-dependent, NADPH oxidase-sensitive pathways in vascular smooth muscle cells from hypertensive patients. Journal of Hypertension, 19: 1245-1254.
31. Touyz RM, Yao G & Schiffrin EL (2003). c-Src induces phosphorylation and translocation of p47phox: Role in superoxide generation by Ang II in human vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 23: 981-987.
32. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y & Griendling KK (2002). Angiotensin II stimulation of NAD(P)H oxidase activity. Upstream mediators. Circulation Research, 91: 406-413.
33. Cosentino F, Barker JE, Brand MP, Heales SJ, Werner ER, Tippins JR, West N, Channon KM, Volpe M & Luscher TF (2001). Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 21: 496-502.
34. Mollnau H, Wendt M, Szocs K et al. (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circulation Research, 90: E58-E65.
35. Vasquez-Vivar J, Duquaine D, Whitsett J, Kalyanaraman B & Rajagopalan S (2002). Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arteriosclerosis, Thrombosis, and Vascular Biology, 22: 1655-1661.
36. Bagi Z & Koller A (2003). Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. Journal of Vascular Research, 40: 47-57.
37. Virdis A, Iglarz M, Neves MF, Amiri F, Touyz RM, Rozen R & Schiffrin EL (2003). Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 23: 1352-1357.
38. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE & Harrison DG (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. Journal of Clinical Investigation, 111: 1201-1209.
39. Mukherjee SP, Lane RH & Lynn WS (1978). Endogenous hydrogen peroxide and peroxidative metabolism in adipocytes in response to insulin and sulfhydryl reagents. Biochemical Pharmacology, 27: 2589-2594.
40. Droge W (2001). Free radicals in the physiological control of cell function. Physiological Reviews, 82: 47-95.
41. Thannickal VJ & Fanburg BL (2000). Reactive oxygen species in cell signaling. American Journal of Physiology, 279: L1005-L1028.
42. Xanthoudakis S & Curran T (1992). Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO Journal, 11: 653-665.
43. Karin M, Liu Z & Zandi E (1997). AP-1 function and regulation. Current Opinion in Cell Biology, 9: 240-246.
44. Anderson JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK & Moller NP (2001). Structural and evolutionary relationships among protein tyrosine phosphatase domains. Molecular and Cellular Biology, 21: 7117-7136.
45. Denu JM & Tanner KG (1998). Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry, 7: 5633-5642.
46. Guillemot L, Levy A, Zhao ZJ, Bereziat G & Rothhut B (2000). The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells. Journal of Biological Chemistry, 275: 26349-26358.
47. Lee SR, Kwon KS, Kim SR & Rhee SG (1998). Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. Journal of Biological Chemistry, 273: 15366-15372.
48. Barrett WC, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB & Chock PB (1999). Regulation of PTPB1 via glutathionylation of the active site cysteine 215. Biochemistry, 38: 6699-6705.
49. Blanchetot C, Tertoolen LGJ & Hertog JD (2002). Regulation of receptor protein tyrosine phosphatase α by oxidative stress. EMBO Journal, 21: 493-503.
50. 2 regulates the activation of distinct MAPK pathways. Free Radical Biology and Medicine, 33: 1121-1132.
51. Torres M & Forman HJ (2003). Redox signaling and the MAP kinase pathways. Biofactors, 17: 287-296.
52. Touyz RM, Deschepper C, Park JB, He G, Chen X, Neves MF, Virdis A & Schiffrin EL (2002). Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats. Journal of Hypertension, 20: 1127-1134.
53. - in vascular smooth muscle cells. Circulation Research, 77: 29-36.
54. Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S & Schiffrin EL (2003). Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells - role of receptor tyrosine kinase transactivation. Canadian Journal of Physiology and Pharmacology, 81: 159-167.
55. Begum N, Ragolia L, Rienzie J, McCarthy M & Duddy N (1998). Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells. Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension. Journal of Biological Chemistry, 273: 25164-25170.
56. Lounsbury KM, Hu Q & Ziegelstein RC (2000). Calcium signaling and oxidant stress in the vasculature. Free Radical Biology and Medicine, 28: 1362-1369.
57. Gao YJ & Lee RM (2001). Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. British Journal of Pharmacology, 134: 1639-1646.
58. Tabet F, Schiffrin EL & Touyz RM (2004). Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from SHR. Journal of Cardiovascular Pharmacology (in press).
59. Nakamura H (2004). Thioredoxin as a key molecule in redox signaling. Antioxidants and Redox Signalling, 6: 15-17.
60. Tanito M, Nakamura H, Kwon YW, Teratani A, Masutani H, Shioji K, Kishimoto C, Ohira A, Horie R & Yodoi J (2004). Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxidants and Redox Signalling, 6: 89-97.